MGHI is launching an international survey to know more about the use of metronomic chemotherapy and drug repositioning to treat children with cancer in LMIC. The questioned have been developed by Dr Gabriel Revon-Rivière and Dr Nicolas André. We aim at sending the survey in central and South America, Africa (GFAOP), Iran, Uganda, Tanzania and India. This survey has 18 items, it is to be answered on-line and requires 10 minutes to be filled. You may be contacted soon by email.